@thewolfofallstreetz Even if you have formulated the question clearly, I would still answer both 😂
I have both in my portfolio and the sectors are too different (pharma vs. textile / sports) for an either or decision.
With Novo Nordisk, things will continue to go up anyway due to the weight loss drugs and with Nike, "only" the new CEO has to deliver, then I am optimistic for the next few years